Tianchang Yifan Pharmaceutical Co., Ltd.
Tianchang Yifan Pharmaceutical Co., Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Platinum-Resistant Ovarian Cancer: A Prospective, Multicenter Clinical Study | Platinum-resistant Ovarian Cancer (PROC) | Not yet recruiting | Phase 4 | 2025-07-20 | NCT07075250 |